Julie Rachline Ph.d.
Bioinformatics & Systems Biology
Bay Zoltan Nonprofit Public Ltd. for Applied Research
France
Biography
Julie joined Advicenne in November 2015 to support corporate development and investor relations. A former VC, Julie invested in diverse companies such as BrainEver, HalioDx, Nanobiotix (Ticker:NANO) or Eurogentec (sold to Kaneka). She was on the board of those companies as well as Voluntis and Stimulus. Julie has also a strong experience in executive search as she was Principal at L3S partnership and was involved in or lead recruitments in pharma, medtech, ANSM or Agence de la Biomédecine organisations. Julie holds a Ph.D. in Neuropharmacology from Ecole Normale Supérieure and a MS from ESCP-Europe.
Research Interest
Bioinformatics & Systems Biology
